|
Information For:
|
Revision Bulletin: PostponementGeneral Chapter <1> Injections Labeling on Ferrules and Cap Overseals SectionPosting Date: August 22, 2008New Official Date: May 1, 2010 Expert Committee: Parenteral Products–Industrial Transfers to Accelerated Revision History section: May 1, 2010 USP has received comments from industry about implementation challenges relating to the Labeling on Ferrules and Cap Overseals section of General Chapter <1> Injections, which appears in USP 31–NF 26, with an official date of February 1, 2009. As a result, and in accordance with the Section 9.08 of the 2005–2010 Rules and Procedures of the Council of Experts, the Parenteral Products–Industrial (PPI) Expert Committee members have voted to delay the official date of the Labeling on Ferrules and Cap Overseals section, as specified in the USP31–NF 26, to May 1, 2010. The PPI Expert Committee's decision to delay the official date is to allow industry time for implementation of the standard. No additional revisions to the section are planned at this time. USP has informed the Food and Drug Administration of this postponement. Should you have any questions, please contact Desmond Hunt, Ph.D., (301–816–8341 or ). What's NewChanges to the Dissolution Performance Verification Test (11/20/09) PF 35(6) Errata (10/30/09) New official Text for October: 15 Revisions Bulletins (10/30/09) Pending Standards for the month of October (10/30/09) PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09) Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09) Elemental Impurities Hot Topics information updated (10/13/09) General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09) Heparin Hot Topics information updated (10/02/09)
Related Resources |
||||||||||||||||||||||||||||
Copyright © 2009 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||